Leizhen Huang
Overview
Explore the profile of Leizhen Huang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
75
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cai B, Huang L, Wang J, Sun D, Zhu C, Huang Y, et al.
Bioconjug Chem
. 2025 Jan;
36(2):309-310.
PMID: 39818801
No abstract available.
2.
Liu Z, Huang L, Qi L, Wang J, Xu H, Yang H, et al.
ACS Appl Mater Interfaces
. 2024 Nov;
16(48):66802.
PMID: 39563634
No abstract available.
3.
Liu Z, Huang L, Qi L, Wang J, Xu H, Yang H, et al.
ACS Appl Mater Interfaces
. 2024 May;
16(19):24384-24397.
PMID: 38709640
Vascularization and inflammation management are essential for successful bone regeneration during the healing process of large bone defects assisted by artificial implants/fillers. Therefore, this study is devoted to the optimization...
4.
Huang L, Du M, Sun D, He M, Liu Z, Wu R, et al.
Small
. 2023 Nov;
20(10):e2306508.
PMID: 37919860
The design and fabrication of NO-evolving core-shell nanoparticles (denoted as NC@Fe), comprised of BNN6-laden COF@Fe O nanoparticles, are reported. This innovation extends to the modification of 3D printed polyetheretherketone scaffolds...
5.
Wu R, Liu Z, Huang Y, Huang L, Wang J, Ding H, et al.
Bioconjug Chem
. 2023 Sep;
34(10):1902-1913.
PMID: 37775152
The emergence of nanozymes presents a promising alternative to antibiotics for reactive oxygen species-mediated broad-spectrum antimicrobial purposes, but nanozymes still face challenges of low therapeutic efficiency and poor biocompatibility. Herein,...
6.
Cai B, Huang L, Zhou X, Zhou X, Lei K, Han M, et al.
Biometals
. 2023 Sep;
37(1):131-142.
PMID: 37682402
The repair and reconstruction of large bone defects after bone tumor resection is still a great clinical challenge. At present, orthopedic implant reconstruction is the mainstream treatment for repairing bone...
7.
Wu R, Huang L, Xia Q, Liu Z, Huang Y, Jiang Y, et al.
Mater Today Bio
. 2023 Aug;
22:100731.
PMID: 37533731
Intervertebral disc degeneration (IDD) is a major contributing factor to both lower back and neck pain. As IDD progresses, the intervertebral disc (IVD) loses its ability to maintain its disc...
8.
Wang J, Huang L, Yang X, Zhu C, Huang Y, He X, et al.
Oxid Med Cell Longev
. 2021 Oct;
2021:1073458.
PMID: 34650661
. Accumulating evidence reported that the microRNA (miRNA) took an important role in intervertebral disc degeneration (IDD). In this study, we revealed a novel miRNA regulatory mechanism in IDD. ....
9.
Zhu C, He M, Sun D, Huang Y, Huang L, Du M, et al.
ACS Appl Mater Interfaces
. 2021 Sep;
13(40):47327-47340.
PMID: 34587454
In this work, we developed the first 3D-printed polyetheretherketone (PEEK)-based bone scaffold with multi-functions targeting challenging bone diseases such as osteosarcoma and osteomyelitis. A 3D-printed PEEK/graphene nanocomposite scaffold was deposited...
10.
Cai B, Huang L, Wang J, Sun D, Zhu C, Huang Y, et al.
Bioconjug Chem
. 2021 Sep;
32(10):2184-2194.
PMID: 34491734
Osteosarcoma is a challenging bone disease which is commonly associated with critically sized bone defects and cancer recurrence. Here, we designed and developed a multifunctional, hierarchical structured bone scaffold which...